Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Timothy Adams

Colon & Rectal Surgery Williamsville, NY Medical Doctor

NPI 1649461401 CMS profile 346763

1150 Youngs Rd, Williamsville, NY 14221

Open in the dashboard

General payments

$3,966

48 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Timothy Adams of Williamsville, NY is reported in the CMS Open Payments database as having received $3,966 across 48 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 57th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,229 10
2024 General $713 13
2023 General $438 6
2022 General $201 4
2021 General $381 4
2020 General $947 7
2019 General $56 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Timothy Adams
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Timothy Adams were reported at $1,229. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Timothy Adams Colon & Rectal Surgery median Middle half National median
2019 $56 $443 $125–$2,179 $163
2020 $947 $167 $53–$931 $114
2021 $381 $207 $72–$1,272 $132
2022 $201 $341 $111–$1,587 $149
2023 $438 $322 $115–$1,420 $160
2024 $713 $328 $112–$1,354 $164
2025 $1,229 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. TELA Bio, Inc. $851 3 payments
  2. Intuitive Surgical, Inc. $607 5 payments
  3. Kestra Medical Technology Services, Inc. $433 10 payments
  4. Ethicon US, LLC $341 3 payments
  5. Davol Inc. $265 4 payments
  6. Axonics Modulation Technologies, Inc. $238 2 payments
  7. Medtronic, Inc. $210 3 payments
  8. Coloplast Corp $171 2 payments
  9. Integra LifeSciences Corporation $164 4 payments
  10. Activ Surgical, Inc. $126 1 payment
  11. Other $559 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,649 45 payments
  2. Travel and Lodging $1,297 2 payments
  3. Education $19 1 payment
Products named General payments · program years 2019–2025
  1. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $827 2 payments
  2. Da Vinci Surgical System $607 5 payments
  3. Assure WCD Cardiology $245 6 payments
  4. VISTASEAL $226 2 payments
  5. Assure WCD Cardiology/Vascular Diseases $188 4 payments
  6. SenSura Mio $171 2 payments
  7. Integra Recon-Skin And Wound $164 4 payments
  8. Integra Recon-Skin And Wound $164 4 payments
  9. INTEGRA DERMAL REGENERATION TEMPLATE $164 4 payments
  10. Phasix Mesh $143 2 payments
  11. Other $2,403 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

52

Median for General Surgery: 59

Drug cost

$157

Median for General Surgery: $393

Branded share of claims

0%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 52 $157

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 67 billing codes

Paid by Medicare

$55,919

Medicare's payments for the services billed

Medicare patients

180

Average age 71

Services billed

413

98 women, 82 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Chronic kidney disease 38%
Diabetes 32%
Ischemic heart disease 29%
Depression 29%
COPD 26%
Cancer 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

48 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record